chrisvoncsefalvay/vaers-outcomes huggingface dataset:
A red circle 2.5 to 3 inches across; it's itchy, not pain, right where the shot was; Big area which was large swollen and red; Itchy area at the injection site; Minimal soreness at site; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of VACCINATION SITE PRURITUS (Itchy area at the injection site), VACCINATION SITE PAIN (Minimal soreness at site), VACCINATION SITE ERYTHEMA (A red circle 2.5 to 3 inches across; it's itchy, not pain, right where the shot was) and VACCINATION SITE SWELLING (Big area which was large swollen and red) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 0146204) for COVID-19 vaccination.     No Medical History information was reported.    On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Jan-2021, the patient experienced VACCINATION SITE PAIN (Minimal soreness at site). On 18-Jan-2021, the patient experienced VACCINATION SITE PRURITUS (Itchy area at the injection site). On 19-Jan-2021, the patient experienced VACCINATION SITE ERYTHEMA (A red circle 2.5 to 3 inches across; it's itchy, not pain, right where the shot was) and VACCINATION SITE SWELLING (Big area which was large swollen and red). On 25-Jan-2021, VACCINATION SITE PRURITUS (Itchy area at the injection site), VACCINATION SITE PAIN (Minimal soreness at site), VACCINATION SITE ERYTHEMA (A red circle 2.5 to 3 inches across; it's itchy, not pain, right where the shot was) and VACCINATION SITE SWELLING (Big area which was large swollen and red) had resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       Treatment information included Benadryl. Patient visited Emergency Room on 21 Jan 2021. Concomitant medications were not provided.   This case was linked to MOD-2021-093957 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 28-Apr-2021: Patient demographics and event stop date changed. Follow-up received on 16-may-2021 contains no new information
PT SAID HER LEFT AXILLARY LYMPHNODES SWELLED UP TO AN EGG-SIZE. PT ALSO EXPERIENCED WEAKNESS GOING DOWN THE INSIDE OF HER ARMPIT DOWN TO HER WRIST.
This spontaneous report as received from a nurse refers to unspecified number of patients of unknown age and gender. No information about medical history, concurrent conditions were reported for the patients. On an unknown date the patients were vaccinated with improperly stored (Oka/Merck) VARIVAX (lot, expiration dates, dose, route unspecified). No adverse effect reported. The outcome of events reported was unknown. Additional information has been requested.
Patient states he did not have significant side effects after the Moderna booster until about 7 days after the shot (about 12/30/21), but then started having dyspnea with exertion, tachycardia and feeling of irregular heart and also had mild chest discomfort.  This lasted for a few days off an on and eventually resolved by 1/4/2022
This spontaneous report as received from a licensed practical nurse, who reported that on 12-AUG-2013, one patient of unknown age and gender received one dose of GARDASIL (lot # H016238, expiration date 11-APR-2015) (dose and route were not reported) exposed to 31F for 84 hours over the past two months, since approximately June 2013. Concomitant medications were not reported. No adverse effects reported. This case is linked to cases 1308USA010552, 1309USA004737, 1309USA004745, and 1309USA004746 via same reported link. Additional information has been requested.
Had 2nd set of vax. Next morning mom notes "urticaria" type of rash - that would flare up and fade. Distribution upper torso, right thigh, left knee, right shoulder, upper arm, left wrist, red, flat 3 cm lesions. Scattered, no pattern.
pt experiencing shoulder pain since date of vaccination, first attept at vaccination hit the bone and vaccine had to be re-inserted, pt will follw up with md to see if effects will be permanent
D68.9 COAGULOPATHY, UNSPECIFIED TYPE 4/26/2022 DM 2 W EYE MANIFESTATION I26.90 SEPTIC PULMONARY EMBOLISM 6/15/2022 DM 2 W EYE MANIFESTATION J96.01 ACUTE HYPOXEMIC RESPIRATORY FAILURE 6/15/2022 DM 2 W EYE MANIFESTATION D68.9 COAGULOPATHY, UNSPECIFIED TYPE 4/26/2022 BACTEREMIA I26.90 SEPTIC PULMONARY EMBOLISM 6/15/2022 BACTEREMIA J96.01 ACUTE HYPOXEMIC RESPIRATORY FAILURE 6/15/2022 BACTEREMIA D68.9 COAGULOPATHY, UNSPECIFIED TYPE 4/26/2022 SEPTIC PULMONARY EMBOLISM I26.90 SEPTIC PULMONARY EMBOLISM 6/15/2022 SEPTIC PULMONARY EMBOLISM J96.01 ACUTE HYPOXEMIC RESPIRATORY FAILURE 6/15/2022 SEPTIC PULMONARY EMBOLISM
Initial information has been received from a pharmacist concerning a patient with an unspecified gender, age, pertinent medical history or drug reactions/allergies, who on 21-DEC-2012, the patient was vaccinated with a expired M-M-R II (exp date 18-DEC-2012) (route, dose were not reported). No other co-suspects were reported. No concomitant medications were reported. No adverse effect reported. No treatment information was reported. The patient's outcome was unknown. Additional information has been requested.
woke up not feeling well, little dizzy & chills, diarrhea. Got worse the next day with nausea & headache.
SWELLING, REDNESS, WARM TO TOUCH FROM INJECTION SITE DOWN TO ELBOW. SYMPTOMS RESOLVED AFTER 10 DAYS.
This spontaneous report was received from a registered nurse via medical assistant and refers to a 12-month-old male patient. The patient's pertinent medical history, concurrent conditions, concomitant medications, past drugs and drug allergies were not reported. On 11-OCT-2017, the patient was vaccinated with improperly stored M-M-R II (lot # M034387; expiry date: 19-JUL-2018) (dosing details were not provided) for prophylaxis. Temperature excursion details of the vaccine were not provided. This is one of the several reports received from the same source. Sender's Comments: US-009507513-1709USA008861: US-009507513-1710USA013424: US-009507513-1710USA013470: US-009507513-1710USA013465: US-009507513-1710USA013440: US-009507513-1710USA013468: US-009507513-1710USA013442: US-009507513-1710USA013445: US-009507513-1710USA013460: US-009507513-1710USA013463: US-009507513-1710USA013464: US-009507513-1710USA013438: US-009507513-1710USA013439: US-009507513-1710USA013450: US-009507513-1710USA013430: US-009507513-1710USA013469: US-009507513-1710USA013467: US-009507513-1710USA013435: US-009507513-1710USA013434: US-009507513-1710USA013432: US-009507513-1710USA013428: US-009507513-1710USA013437: US-009507513-1710USA013441: US-009507513-1710USA013443: US-009507513-1710USA013444: US-009507513-1710USA013446: US-009507513-1710USA013447: US-009507513-1710USA013448: US-009507513-1710USA013436: US-009507513-1710USA013449: US-009507513-1710USA013451: US-009507513-1710USA013452: US-009507513-1710USA013454: US-009507513-1710USA013455: US-009507513-1710USA013456: US-009507513-1710USA013457: US-009507513-1710USA013458: US-009507513-1710USA013459: US-009507513-1710USA013461: US-009507513-1710USA013462: US-009507513-1710USA013466: US-009507513-1710USA013427: US-009507513-1710USA013471: US-009507513-1710USA013472: US-009507513-1710USA013473: US-009507513-1710USA013474: US-009507513-1710USA013475: US-009507513-1710USA013476: US-009507513-1710USA013425: US-009507513-1710USA013433: US-009507513-1710USA013423: US-009507513-1710USA013040: US-009507513-1710USA013426: US-009507513-1710USA013429: US-009507513-1710USA013431: US-009507513-1709USA008666: Original Case: 1709USA008666: US-009507513-1710USA014650: Original Case: 1710USA014649: US-009507513-1710USA014651: Original Case: 1710USA014649: US-009507513-1710USA014649: Original Case: 1710USA014649.
Warm legs; Little sore arm; This spontaneous case was reported by a consumer and describes the occurrence of HOT FLUSH (Warm legs) and PAIN IN EXTREMITY (Little sore arm) in a 63-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concomitant products included INSULIN for an unknown indication.    On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Mar-2021, the patient experienced HOT FLUSH (Warm legs) and PAIN IN EXTREMITY (Little sore arm). At the time of the report, HOT FLUSH (Warm legs) and PAIN IN EXTREMITY (Little sore arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications included unspecified blood pressure medications No treatment information was provided.
Headache; Red eyes; Chills; This is a spontaneous report from a contactable consumer or other non hcp (patient's wife). A 66-years-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot Number: EN6206), via an unspecified route of administration, administered in Arm Left on 18Mar2021 01:30 (at the age of 66-year-old) as dose 1, single for covid-19 immunisation.  Medical history included asthma from an unknown date and unknown if ongoing. Concomitant medications included fluticasone furoate, umeclidinium bromide, vilanterol trifenatate (TRELEGY) taken for asthma, start and stop date were not reported. Patient previously received flu vaccine for immunisation about two months ago. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 18Mar2021, the patient experienced chills. On 19Mar2021, patient experienced headache, red eyes. Clinical course: patient got chills later in the afternoon on 18Mar2021, and that his chills have improved since then. patient then got a headache, and his headache was real bad and keeps getting worse, and his eyes are really red. Reporter stated that on 23Mar2021 was the worse headache patient ever had in his life. Reporter asked if the patient can get second dose. The events were reported as non serious. Therapeutic measures taken as a result of event headache included Tylenol and ibuprofen and also taking over-the-counter Visine for his red eyes. Events did not result in emergency room or physician office visit. The outcome of the event chills was recovering and headache, red eyes were not recovered.   Follow-up attempts are completed. No further information is expected.
Mom presented to clinic for EPSDT, Immunizations, and Nutritional Education appointment. EPSDT and Immunizations were done as per protocol and when entering the Immunizations into the registry it was found that the immunizations had already been given at Clinic on 12/26/2018.  Dr., medical director and, VAERS coordinator were contacted and the mother was attempted to contact numerous times with messages left to call back. Mother returned call on 1/7/2019 and was informed that vaccines were given too soon as per schedule. Mother reported there had been no adverse reactions with the infant since the immunizations, no redness, no swelling, and that the infant was doing fine.
Immediately with flu vaccine injection, I felt a rushing pain at the injection site (left upper arm). Since then, I have had increasing pain in my upper arm (shoulder area). It is difficult to get dressed & raise my arm above my head in certain directions. I also still feel pain like a bruise at the injection site when I touch it. All of these symptoms are still felt as of today, 1/2/14 almost one month post vaccine.
Child started have rash hives on body, eye swelling and told mom he is having problems with breathing and crying - Seen immediately in ER.
Tingling and numbness of feet ascending up legs, muscle pain and weakness in legs and arms, flushing of face, dizziness, nausea, all occurring over two weeks and worsening; given Medrol dose pak which lessened symptoms and then numbness returned when stopped; still has muscle weakness, numbness, headache, problems with concentration and writing, twitching and pain.  12/9/2009 ED records for 11/20/2009, patient with c/o's joint and muscle pain, tx'd with IV Solu-Medrol, DC DX post vaccine syndrome
SWEELING OF THE NECK , THROAT AND TONGUE- UNABLE TO BREATHE.
Fever (100-102), chills, pain and stiffness in shoulder, elevated pulse (100-110), arrhythmia, weakness, shortness of breath Treated with ibuprofen, acetaminophen, aspirin, electrolytes, multivitamin supplement
Patient fainted. She faints after all immunizations according to her and her father.  She was fine, laid down, raised feet, ice pack on forehead/neck. She rested and left after 15 minutes
pt recvd vax; arm swelling from inj site to elbow & down under arm;no rash, no fever or chills noted;
15 month well baby exam 05/07/2003-slight nasal congestion.  Received DTAP #3, Hib #3, Prevnar #1 at 15:00.  05/07/2003: Evening temp to 102.3, irritable and up all night.  05/08/2003: Temp 100-101 F, slight high congestion/cough.  05/09/2003 AM: Temp 99 F, woke from PM nap with 103 F-To clinic at 14:00.  Temp: 105.6 (tym) 105 (R); Chest X-ray- Pneumonia, given rocephin IM.  Follow up 05/10/2003.  Temp: 100.3.
Mother states patient had rash entire body (not itchy), 1 day after vaccines lasting 1 day, no other symptoms.
About 56 hrs after Tdap redness around injection site which was rounded and red. Red dots about "8" spread over my chest and below chest & above diaphragm. Also noted redness in inside elbows.
1st dose for 30mins after the vaccine, my saliva gland on my right side went into overdrive and under my right ear mouth was like an ache for 10 mins, Sinus Infection in Feb2022, my husband tested positive I was negative. Been having sinus infection and had virtual health and the doctor had me a COVID test and I don't have the results. I had my 3rd booster in 11Sep2021.
The vaccine was not mixed with the diluent in the box with the vaccine but with sterile diluent.
fever; This is a spontaneous report from a contactable physician.  A 27-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, Lot number EK9231), intramuscularly, on 24Dec2020 at 13:30 (at the age of 27 years old) at an unspecified dose in the left arm for COVID-19 Vaccination. Medical history included obesity, migraine and bipolar disorder from unknown dates. Prior to vaccination, the patient was diagnosed with COVID-19 (date not specified).The patient's known allergies included shellfish products and chocolate.The patient was administered the vaccine in the hospital. It was unknown if the patient was pregnant at the time of the vaccination. Concomitant medication included ergocalciferol (ERGOCALCIFEROL), rizatriptan (RIZATRIPTAN), tretinoin (TRETINOIN). It was unknown if the patient had received any other vaccines within four weeks prior to the vaccination. On 25Dec2020, the patient experienced fever (no value reported). The patient did not receive any treatment for the event. The clinical outcome of fever was not recovered. It was also reported that since the vaccination the patient had not been tested for COVID-19.
Itching in my scalp; heat bothers it more that the cold weather; This is a spontaneous report from a contactable consumer or other non-health care professional (Patient). A 78-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot Number: EK9231 and Expiration date was not reported), first dose via an unspecified route of administration on 07Jan2021 (at the age of 78 years) single for covid-19 immunisation. Patient Medical history included hypertension and Heart Attack from an unknown date and unknown if ongoing. Concomitant medication(s) included clopidogrel bisulfate (Plavix, 75 MG), Metoprolol, Benazepril and amlodipine besilate (Norvasc, 2.5 MG) taken for an unspecified indication, start and stop date were not reported. On an unspecified date (4 days after vaccination) the patient experienced itching in scalp which is bothered in heat more that the cold weather. Outcome of the event was unknown.   Follow-up attempts completed. No further information expected.
tooth infection; This is a spontaneous report from a contactable consumer (patient). A female patient of unspecified age received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; solution for injection), via an unspecified route of administration on an unspecified date as a single dose for COVID-19 immunisation. The patient had no other products taken together with those indicated above. The patient medical history was not reported. On an unspecified date, the patient had tooth infection and was on an antibiotic and was wondering if the antibiotic will affect the vaccine. It was unknown, whether patient was admitted to the hospital due to event. The clinical outcome for the event was unknown.  Follow-up attempts are needed. Information on the lot/batch number has been requested.
Site: Bruising at Injection Site-Mild, Site: Itching at Injection Site-Mild, Site: Pain at Injection Site-Mild, Site: Redness at Injection Site-Mild, Site: Swelling at Injection Site-Mild, Systemic: Chest Tightness / Heaviness / Pain-Mild
This prospective report has been received from a nurse referring to a 23 year old female patient. Medication history and drug allergy were not reported. On 22-APR-2015 the patient was vaccinated with the third dose of GARDASIL (dose and route were not reported, lot # K009482, expire date 06-MAR-2017) while she was 20 weeks pregnant (second trimester). Concomitant drug was not reported. Her last menstrual period (LMP) was 03-DEC-2014 and estimated date of delivery (EDD) was 09-SEP-2015. No adverse effects were reported. No treatment was given. At the time of reporting, the pregnancy outcome was pending. Additional information has been requested.
This spontaneous report as received from a pharmacist refers to a male patient of unknown age. On an unknown date the patient was vaccinated with GARDASIL (dose 3; route, dosage and lot number unknown). The pharmacist reported that the patient received the third dose of GARDASIL on an unspecified date approximately 1.5 years after the second dose. The pharmacist did not know the dates the patient received any of the previous doses. No adverse symptoms were reported. Additional information has been requested.
Information has been received from a Doctor of Pharmacy concerning a female patient who on 21-APR-2011, was vaccinated with a dose of ZOSTAVAX (Merck) (lot number, dose and site of administration not reported). On 23-APR-2011, the patient experienced water blisters on her face, arm and leg. The patient only had the "rash" on the left side of the body. Also, it was noticed that the rash that was believed to be caused by ZOSTAVAX was a poison ivy rash, not related to the ZOSTAVAX. The patient received unspecified medical attention. At the time of the report, the patient's outcome was unknown. Additional information has been requested.
13 month old with 1st seizure episode. had MMRV vaccine morning of 7/20, father noted in afternoon that while pt was playing, she then started have jerking movement of body, exts lasted ~1min this afternoon. Somewhat tired afterwards. Brought pt to clinic and pt was already back to baseline. No reported fever. At the clinic, axillary temp was 99.2, rectal temp was 99.2. Pt's been doing well since the episode. No reported additional fever. Baseline blood work for lytes/glc were ok. Past medical hx: "small ASD and possible mild pulmonary valve stenosis" from cardio eval previously. otherwise, healthy.
pt recv vax 26SEP95&6OCT95 pt presented w/cough which was tx w/pediapred;21OCT95 pt cont w/cough&also had congestion which was treated w/Ventolin;MD dx as having whooping cough on 24OCT95;pt treated w/ER;
Patient came into pharmacy on 10/24 and showed a approx 4" round bruise at injection site on (L) arm. It is slightly warm and sore to the touch. She stated it is improving.
a low grade with temperatures below 100°F; feeling tired about having fever; not feeling well; not feeling normal; This spontaneous case was reported by a patient and describes the occurrence of MALAISE (not feeling well), FEELING ABNORMAL (not feeling normal), PYREXIA (a low grade with temperatures below 100°F) and FATIGUE (feeling tired about having fever) in a 71-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7140C) for COVID-19 vaccination.     The patient's past medical history included Renal and pancreas transplant. Previously administered products included for Product used for unknown indication: Pfizer (Dose 1, events only lasted for 48 hours.) on 22-Jan-2021, Pfizer (Dose 2, events only lasted for 48 hours.) on 13-Feb-2021, Pfizer (Dose 3, 1st booster dose, events only lasted for 48 hours.) on 16-Aug-2021, Pfizer (Dose 4, 2nd booster dose, events only lasted for 48 hours.) on 29-Mar-2022 and prevnar 20 pneumonia vaccination (received 48 hours before receiving the bivalent booster) on 07-Sep-2022. Past adverse reactions to the above products included No adverse event with prevnar 20 pneumonia vaccination; and Vaccination adverse reaction with Pfizer, Pfizer, Pfizer and Pfizer. Concurrent medical conditions included Sulfonamide allergy (sulfa), Drug allergy (morphine) and Allergy to antibiotic (cipro antibiotics.).    On 09-Sep-2022, the patient received fifth dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 10-Sep-2022, the patient experienced PYREXIA (a low grade with temperatures below 100°F). In September 2022, the patient experienced MALAISE (not feeling well), FEELING ABNORMAL (not feeling normal) and FATIGUE (feeling tired about having fever). At the time of the report, MALAISE (not feeling well), FEELING ABNORMAL (not feeling normal), PYREXIA (a low grade with temperatures below 100°F) and FATIGUE (feeling tired about having fever) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 10-Sep-2022, Body temperature: below 100°F..         It was reported that patient took concomitant medication but were not specified.  It was reported that patient was going to call her doctor that morning, already reported to the agency. she had never experienced a similar event in the past.  Patient had never diagnosed with COVID nor had COVID positive test .  No treatment medication were reported.
A little bit of sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (A little bit of sore arm) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 26-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (A little bit of sore arm). At the time of the report, PAIN IN EXTREMITY (A little bit of sore arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported.  No treatment information was provided.   This case was linked to MOD-2021-133096, MOD-2021-133200 (Patient Link).
Severe headache, fatigue, nausea, disorientation and loss of visual field on the right side.  Started the morning of September 10th, most resolved by the afternoon except for the headache and fatigue. The headache began as a severe pain behind my left eye and has since transferred to my entire head.